Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2993128425', 'doi': None, 'title': 'Core Programs Drive International Drug Marketing', 'display_name': 'Core Programs Drive International Drug Marketing', 'publication_year': 1994, 'publication_date': '1994-03-01', 'ids': {'openalex': 'https://openalex.org/W2993128425', 'mag': '2993128425'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.questia.com/library/journal/1G1-15317685/core-programs-drive-international-drug-marketing', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S27475527', 'display_name': 'Public relations journal', 'issn_l': '0033-3670', 'issn': ['0033-3670'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316515', 'host_organization_name': 'Public Relations Society of America', 'host_organization_lineage': ['https://openalex.org/P4310316515'], 'host_organization_lineage_names': ['Public Relations Society of America'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5018206395', 'display_name': 'Laura Schoen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Laura Schoen', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5018206395'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 53}, 'biblio': {'volume': '50', 'issue': '3', 'first_page': '28', 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11649', 'display_name': 'Pharmaceutical industry and healthcare', 'score': 0.5611, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11649', 'display_name': 'Pharmaceutical industry and healthcare', 'score': 0.5611, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/sophistication', 'display_name': 'Sophistication', 'score': 0.42632952}], 'concepts': [{'id': 'https://openalex.org/C2119116', 'wikidata': 'https://www.wikidata.org/wiki/Q7181', 'display_name': 'Globalization', 'level': 2, 'score': 0.64960575}, {'id': 'https://openalex.org/C162853370', 'wikidata': 'https://www.wikidata.org/wiki/Q39809', 'display_name': 'Marketing', 'level': 1, 'score': 0.5157795}, {'id': 'https://openalex.org/C97509610', 'wikidata': 'https://www.wikidata.org/wiki/Q3141064', 'display_name': 'Internationalization', 'level': 2, 'score': 0.48061627}, {'id': 'https://openalex.org/C2779652045', 'wikidata': 'https://www.wikidata.org/wiki/Q507443', 'display_name': 'Pharmaceutical industry', 'level': 2, 'score': 0.44257227}, {'id': 'https://openalex.org/C160735492', 'wikidata': 'https://www.wikidata.org/wiki/Q31207', 'display_name': 'Health care', 'level': 2, 'score': 0.43445638}, {'id': 'https://openalex.org/C168725872', 'wikidata': 'https://www.wikidata.org/wiki/Q991663', 'display_name': 'Sophistication', 'level': 2, 'score': 0.42632952}, {'id': 'https://openalex.org/C144133560', 'wikidata': 'https://www.wikidata.org/wiki/Q4830453', 'display_name': 'Business', 'level': 0, 'score': 0.42037487}, {'id': 'https://openalex.org/C39549134', 'wikidata': 'https://www.wikidata.org/wiki/Q133080', 'display_name': 'Public relations', 'level': 1, 'score': 0.40769514}, {'id': 'https://openalex.org/C50522688', 'wikidata': 'https://www.wikidata.org/wiki/Q189833', 'display_name': 'Economic growth', 'level': 1, 'score': 0.27474704}, {'id': 'https://openalex.org/C162324750', 'wikidata': 'https://www.wikidata.org/wiki/Q8134', 'display_name': 'Economics', 'level': 0, 'score': 0.25169802}, {'id': 'https://openalex.org/C144024400', 'wikidata': 'https://www.wikidata.org/wiki/Q21201', 'display_name': 'Sociology', 'level': 0, 'score': 0.21997029}, {'id': 'https://openalex.org/C155202549', 'wikidata': 'https://www.wikidata.org/wiki/Q178803', 'display_name': 'International trade', 'level': 1, 'score': 0.19230843}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.17200828}, {'id': 'https://openalex.org/C34447519', 'wikidata': 'https://www.wikidata.org/wiki/Q179522', 'display_name': 'Market economy', 'level': 1, 'score': 0.12534508}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.12524298}, {'id': 'https://openalex.org/C36289849', 'wikidata': 'https://www.wikidata.org/wiki/Q34749', 'display_name': 'Social science', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.questia.com/library/journal/1G1-15317685/core-programs-drive-international-drug-marketing', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S27475527', 'display_name': 'Public relations journal', 'issn_l': '0033-3670', 'issn': ['0033-3670'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316515', 'host_organization_name': 'Public Relations Society of America', 'host_organization_lineage': ['https://openalex.org/P4310316515'], 'host_organization_lineage_names': ['Public Relations Society of America'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/17', 'display_name': 'Partnerships for the goals', 'score': 0.57}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W60455394', 'https://openalex.org/W410727427', 'https://openalex.org/W331261433', 'https://openalex.org/W2993089143', 'https://openalex.org/W280123301', 'https://openalex.org/W268872346', 'https://openalex.org/W268836919', 'https://openalex.org/W266950499', 'https://openalex.org/W2316974973', 'https://openalex.org/W2199123767', 'https://openalex.org/W216960250', 'https://openalex.org/W212865087', 'https://openalex.org/W2059840248', 'https://openalex.org/W2052512196', 'https://openalex.org/W201669455', 'https://openalex.org/W178733495', 'https://openalex.org/W1600498804', 'https://openalex.org/W1575653361', 'https://openalex.org/W1522758889', 'https://openalex.org/W1172142276'], 'abstract_inverted_index': {'The': [491], 'dynamics': [1], 'of': [2, 35, 80, 86, 125, 148, 163, 169, 222, 230, 238, 270, 293, 303, 328, 354, 365, 412, 422, 433, 443], 'the': [3, 11, 18, 33, 36, 56, 102, 128, 130, 134, 140, 167, 197, 233, 236, 250, 259, 290, 300, 326, 392, 394, 404, 423, 451, 474, 505, 532, 535], 'international': [4, 180, 315], 'pharmaceutical': [5, 103, 136, 399, 467, 563], 'industry': [6, 137], 'have': [7, 138, 158, 210, 280, 334, 401], 'changed': [8], 'dramatically': [9], 'in': [10, 55, 97, 108, 133, 160, 196, 203, 218, 232, 249, 314, 453, 522, 544, 549, 554], 'past': [12], '20': [13, 68, 352], 'years.': [14], 'In': [15, 306], 'earlier': [16], 'times,': [17], 'largest': [19, 395], 'drug': [20, 42, 445, 521, 550], 'manufacturers': [21], 'were': [22], 'mostly': [23], 'U.S.-based.': [24], 'Their': [25], 'inroads': [26], 'into': [27], 'other': [28], 'countries': [29, 271], 'often': [30], 'did': [31], 'incorporate': [32], 'needs': [34, 292], 'local': [37, 308, 332, 378], 'markets.': [38, 305], 'As': [39], 'a': [40, 122, 170, 184, 311, 322, 344, 362, 441, 520], 'result,': [41], 'products': [43, 400], 'and': [44, 64, 82, 145, 156, 166, 173, 183, 192, 205, 219, 240, 276, 374, 381, 407, 415, 496, 513, 552], 'marketing': [45, 450, 483], 'techniques': [46], 'merely': [47], 'copied': [48], 'successful': [49], 'strategies': [50, 182], 'which': [51], 'had': [52], 'been': [53, 106, 321, 403], 'developed': [54, 555], "company's": [57, 171], 'U.S.': [58], 'operations.': [59], 'What': [60], 'I': [61, 66], 'see': [62], 'today': [63], 'what': [65, 517], 'saw': [67], 'years': [69, 353], 'ago': [70], 'are': [71, 357, 469, 499, 542], 'greatly': [72], 'different,': [73], 'said': [74, 341], 'Herb': [75], 'von': [76], 'Bargen,': [77], 'former': [78], 'director': [79], 'operations': [81], 'area': [83], 'vice': [84], 'president': [85], 'American': [87], 'Home': [88], 'Products,': [89], 'Latin': [90], 'America.': [91], 'parent': [93], 'company': [94, 154], 'is': [95, 194, 438, 493], 'based': [96], 'New': [98, 345], 'York': [99, 346], 'City.': [100], 'Although': [101], 'business': [104], 'has': [105, 226, 253, 320, 427], 'worldwide': [107], 'scope': [109], 'for': [110, 186, 245, 398], 'some': [111, 466], 'time,': [112], "there's": [113], 'now': [114, 409], 'much': [115, 358], 'more': [116, 337, 359], 'emphasis': [117], 'on': [118, 539], 'thinking': [119], 'strategically': [120], 'from': [121], 'global': [123, 135, 187, 220, 291, 566], 'point': [124], 'view.': [126], 'Over': [127], 'years,': [129], 'following': [131], 'changes': [132], 'impacted': [139], 'way': [141], 'health': [142, 223, 246, 267, 329, 375], 'care': [143, 224, 247, 268, 376], 'professionals': [144], 'their': [146, 294], 'cadre': [147], 'consultants': [149], 'do': [150], 'business:': [151], '*': [152, 176, 189, 207, 215, 228, 242], 'Pharmaceutical': [153], 'mergers': [155], 'acquisitions': [157], 'resulted': [159], 'an': [161, 429], 'internationalization': [162, 327], 'corporate': [164], 'identity': [165], 'globalization': [168, 237], 'economic': [172], 'research': [174], 'base;': [175], 'Cost-containment': [177], 'drives': [178], 'encourage': [179], 'pricing': [181], 'search': [185], 'markets;': [188], 'Consumer': [190], 'education': [191], 'sophistication': [193], 'growing': [195], 'United': [198, 251, 405, 475], 'States': [199, 252, 406], 'as': [200, 202, 212, 273, 370, 556], 'well': [201], 'Europe': [204], 'Japan;': [206], 'Constituency': [208], 'organizations': [209], 'emerged': [211], 'key': [213], 'influencers;': [214], 'Media': [216], 'interest': [217], 'coverage': [221], 'issues': [225], 'increased;': [227], 'Cross-pollination': [229], 'cultures': [231], 'workplace': [234], 'promotes': [235], 'creativity': [239], 'ideas;': [241], 'movement': [244], 'reform': [248], 'reached': [254], 'center': [255], 'stage': [256], 'along': [257], 'with': [258, 263, 351, 410], 'debate': [260], 'about': [261], 'problems': [262], 'single-payer': [264], '(government': [265], 'funded)': [266], 'systems': [269], 'such': [272, 369], 'Canada,': [274], 'Germany': [275], 'France.': [277], 'These': [278], 'developments': [279], 'challenged': [281], 'public': [282], 'relations': [283], 'firms': [284], 'to': [285, 288, 299, 361, 471, 519, 558], 'find': [286], 'ways': [287], 'address': [289], 'clients': [295], 'while': [296, 318], 'remaining': [297], 'sensitive': [298, 360, 460], 'specific': [301, 367], 'agenda': [302], 'national': [304, 371], 'fact,': [307], 'markets': [309, 397], 'play': [310], 'pivotal': [312], 'role': [313], 'strategies.': [316, 567], 'Interestingly,': [317], 'there': [319], 'strong': [323], 'trend': [324], 'toward': [325, 440], 'care,': [330], 'certain': [331], 'constants': [333], 'also': [335], 'engendered': [336], 'globally': [338], 'cooperative': [339], 'perspectives,': [340], 'Saralie': [342], 'Slonsky,': [343], 'City-based': [347], 'medical': [348], 'communications': [349], 'consultant': [350], 'experience.': [355], 'Companies': [356], 'wide': [363], 'range': [364], 'culturally': [366, 459], 'issues,': [368], 'government': [372], 'regulations': [373], 'practices,': [377], 'media': [379], 'opportunities,': [380], 'demographic': [382], 'factors': [383], 'affecting': [384], 'each': [385, 454, 510], 'market,': [386], 'she': [387], 'added.': [388], 'Toward': [389], 'harmonization': [390], 'Since': [391], "'60s,": [393], 'single': [396], 'traditionally': [402], 'Japan,': [408], 'populations': [411], '250': [413], 'million': [414, 435], '125': [416], 'million,': [417], 'respectively.': [418], 'recent': [420], 'establishment': [421], '12-nation': [424], 'European': [425], 'Union': [426], 'created': [428], 'even': [430], 'larger': [431], 'market': [432, 524], '320': [434], 'people.': [436], 'Harmonization': [437], 'leading': [439], 'practice': [442], 'approving': [444], 'applications': [446, 553], 'throughout': [447], 'Europe,': [448], 'but': [449], 'product': [452, 481], 'country': [455, 492], 'will': [456], 'still': [457], 'demand': [458], 'programs.': [461], "It's": [462], 'not': [463], 'unlike': [464], 'how': [465, 540], 'companies': [468], 'starting': [470], 'look': [472], 'at': [473, 485], 'States,': [476], 'noted': [477], 'Denise': [478], 'Sheehan,': [479], 'senior': [480], 'manager,': [482], 'planning,': [484], 'Parke-Davis': [486], 'Group,': [487], 'Morris': [488], 'Plains,': [489], 'NJ.': [490], 'segmented': [494], 'geographically,': [495], 'different': [497], 'areas': [498], 'being': [500], 'addressed': [501], 'slightly': [502], 'differently.': [503], 'Meanwhile,': [504], "world's": [506], 'regulatory': [507], 'agencies': [508], 'monitor': [509], "other's": [511], 'activities': [512], 'share': [514], 'information,': [515], 'so': [516], 'happens': [518], 'one': [523], 'affects': [525], 'its': [526], 'status': [527], 'worldwide,': [528], 'Sheehan': [529], 'said.': [530], 'When': [531], 'FDA': [533], 'speaks,': [534], 'world': [536], 'listens.': [537], 'Statistics': [538], 'drugs': [541], 'marketed': [543], 'various': [545], 'countries,': [546, 560], 'especially': [547], 'differences': [548], 'uses': [551], 'opposed': [557], 'developing': [559], 'can': [561], 'help': [562], 'marketers': [564], 'plot': [565], '…': [568]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2993128425', 'counts_by_year': [], 'updated_date': '2024-12-14T04:31:50.320480', 'created_date': '2019-12-13'}